Stroke Risk Stratification in a “Real-World” Elderly Anticoagulated Atrial Fibrillation Population

Improving Stroke Risk Stratification in Atrial Fibrillation

(2010) Gregory Y.H. Lip et al.   AMERICAN JOURNAL OF MEDICINE

Anticoagulation for Atrial Fibrillation Patients with CHADS2Score of 1

(2010) DEIRDRE A. LANE et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1

(2010) Laurent Gorin et al.   THROMBOSIS AND HAEMOSTASIS

Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at ‘moderate risk’ [CHADS2 score=1]: Simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice

(2010) Gregory Lip   THROMBOSIS AND HAEMOSTASIS

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Warfarin Is Not Needed in Low-Risk Patients Following Atrial Fibrillation Ablation Procedures

(2009) T. JARED BUNCH et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

The Effect and Safety of the Antithrombotic Therapies in Patients with Atrial Fibrillation and CHADS2Score 1

(2009) BYUNG HO LEE et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Antithrombotic Therapy in Atrial Fibrillation

(2008) Daniel E. Singer et al.   CHEST

Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk

(2008) Jeff S. Healey et al.   STROKE

Disparate Stroke Rates on Warfarin Among Contemporaneous Cohorts With Atrial Fibrillation

(2008) Elaine M. Hylek et al.   STROKE